0001209191-20-065582.txt : 20201230
0001209191-20-065582.hdr.sgml : 20201230
20201230181653
ACCESSION NUMBER: 0001209191-20-065582
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201230
FILED AS OF DATE: 20201230
DATE AS OF CHANGE: 20201230
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Terrillion Scott
CENTRAL INDEX KEY: 0001706426
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36279
FILM NUMBER: 201427009
MAIL ADDRESS:
STREET 1: C/O CARA THERAPEUTICS, INC.
STREET 2: 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL
CITY: STAMFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001346830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4 STAMFORD PLAZA
STREET 2: 107 ELM STREET 9TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-406-3700
MAIL ADDRESS:
STREET 1: 4 STAMFORD PLAZA
STREET 2: 107 ELM STREET 9TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
FORMER COMPANY:
FORMER CONFORMED NAME: Cara Therapeutics Inc
DATE OF NAME CHANGE: 20051213
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-30
0
0001346830
Cara Therapeutics, Inc.
CARA
0001706426
Terrillion Scott
C/O CARA THERAPEUTICS, INC.
4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL
STAMFORD
CT
06902
0
1
0
0
Sec'y; Chief Compliance & G.C.
Common Stock
2020-12-30
4
S
0
1946
15.30
D
42436
D
This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of the RSUs reported on Form 4 filed with the Securities and Exchange Commission on December 29, 2020, and does not represent a discretionary trade by the Reporting Person.
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding as described in footnote (1).
/s/ Darren DeStefano, Attorney-in-Fact
2020-12-30